Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.77B | 6.91B | 5.42B | 4.92B | 4.40B |
Gross Profit | 1.89B | 1.47B | 1.30B | 1.16B | 1.04B |
EBITDA | 807.85M | 456.65M | 506.91M | 426.76M | 349.64M |
Net Income | 480.57M | 239.28M | 301.79M | 274.08M | 239.61M |
Balance Sheet | |||||
Total Assets | 5.82B | 4.58B | 4.28B | 3.16B | 2.60B |
Cash, Cash Equivalents and Short-Term Investments | 2.21B | 1.81B | 1.18B | 1.13B | 714.28M |
Total Debt | 1.61B | 1.04B | 1.12B | 644.03M | 337.61M |
Total Liabilities | 3.36B | 2.52B | 2.38B | 1.45B | 1.05B |
Stockholders Equity | 2.45B | 2.06B | 1.90B | 1.69B | 1.55B |
Cash Flow | |||||
Free Cash Flow | 452.39M | 468.23M | 151.50M | 465.11M | -21.28M |
Operating Cash Flow | 526.35M | 514.11M | 235.19M | 484.67M | -6.67M |
Investing Cash Flow | -567.04M | 271.39M | -500.66M | -107.60M | -678.94M |
Financing Cash Flow | 478.30M | -153.56M | 308.35M | 43.46M | -197.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥4.47B | 9.66 | 3.22% | 27.51% | 68.04% | ||
73 Outperform | ¥4.13B | 20.13 | ― | -1.23% | 2.92% | ||
63 Neutral | ¥4.08B | 18.60 | 3.26% | 2.04% | -3.43% | ||
62 Neutral | £507.79M | 27.20 | -2.10% | 2.80% | 3.87% | -14.52% | |
62 Neutral | ¥4.13B | 1,280.01 | ― | -2.43% | -78.05% | ||
61 Neutral | ¥3.79B | 38.01 | ― | 17.03% | 642.80% | ||
52 Neutral | ¥4.10B | 35.63 | 0.55% | 18.43% | 22.38% |